International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 13, 2024, after the close
10-Q filed Aug 13, 2024, 44 days after period end · 0000950170-24-096128
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $2.33M | $1.84M | $2.03M | $1.83M |
| Net Income | $119.00K | $492.00K | -$2.00K | $216.00K |
| EPS Diluted | $0.01 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.03 |
| $0.00 |
| $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
